Transplantation and Cellular Therapy

Published by: Elsevier Inc.  

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Scordo
    Scordo
  4. Shah
    Shah
  5. Dahi
    Dahi
  6. Lin
    Lin
  7. Palomba
    Palomba
  8. Park
    Park
  9. Salles
    Salles
  10. Shouval
    Shouval

Groups

  1. Sloan Kettering Institute Postdocs (15)
  2. Department of Medicine (14)
  3. Center for Hematologic Malignancies (13)
  4. Hematologic Malignancies, Division of (12)
  5. Bone Marrow Transplant (10)
  6. GSK Faculty (10)
  7. Epidemiology and Biostatistics (8)
  8. Biostatistics Service (7)
  9. Human Oncology and Pathogenesis Program (7)
  10. CTCR Scholars (6)
Search Within
  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (9)
  2. Meeting Abstract (6)
Groups
  1. Sloan Kettering Institute Postdocs (15)
  2. Department of Medicine (14)
  3. Center for Hematologic Malignancies (13)
  4. Hematologic Malignancies, Division of (12)
  5. Bone Marrow Transplant (10)
  6. GSK Faculty (10)

More Groups

People
  1. Gunjan Shah (5)
  2. Jessica Flynn (5)
  3. Michael Scordo (5)
  4. Miguel-Angel Perales (5)
  5. Sergio Giralt (5)
  6. Ana Alarcon Tomas (4)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (2)
  4. 2022 (8)
  5. 2021 (2)
Publishers
  1. Elsevier Inc. (15)

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Enhancing the persistence and anti-tumor efficacy of CAR-T and CAR-NK cells through genetic disruption of death receptors
    Meeting Abstract

    Cohen, T. D.; Yi, F.; Zumbo, P.; Etilib, R.; Arkin, H.; Gormally, M.; Hackett, C. S.; Kropp, K.; Etxeberria, I.; Chandran, S. S.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Subsequent malignancies after CD19-targeted chimeric antigen receptor T cells in patients with lymphoma
    Journal Article

    Lorenc, R.; Shouval, R.; Flynn, J. R.; Devlin, S. M.; Saldia, A.; Luna De Abia, A.; De Lapuerta, M. C.; Tomas, A. A.; Cassanello, G.; Leslie, L. A.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Persistent or new cytopenias predict relapse better than routine bone marrow aspirate evaluations after hematopoietic cell transplantation for acute leukemia or myelodysplastic syndrome in children and young adult patients
    Journal Article

    Kernan, N. A.; Klein, E.; Mauguen, A.; Torok-Castanza, J.; Prockop, S. E.; Scaradavou, A.; Curran, K.; Spitzer, B.; Cancio, M.; Ruggiero, J.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Profiling the fungal microbiome after fecal microbiota transplantation for graft-versus-host disease: Insights from a phase 1 interventional study
    Journal Article

    van Lier, Y. F.; Rolling, T.; Armijo, G. K.; Zhai, B.; Haverkate, N. J. E.; Meijer, E.; Nur, E.; Blom, B.; Peled, J. U.; van den Brink, M. R. M.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Bridging radiation rapidly and effectively cytoreduces high-risk relapsed/refractory aggressive B cell lymphomas prior to chimeric antigen receptor T cell therapy
    Journal Article

    Hubbeling, H.; Silverman, E. A.; Michaud, L.; Tomas, A. A.; Shouval, R.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Tringale, K. R.; Batlevi, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Vitamin D insufficiency and clinical outcomes with chimeric antigen receptor T-cell therapy in large B-cell lymphoma
    Journal Article

    Nath, K.; Tomas, A. A.; Flynn, J.; Fein, J. A.; Alperovich, A.; Anagnostou, T.; Batlevi, C. L.; Dahi, P. B.; Fingrut, W. B.; Giralt, S. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Vitamin D deficiency is associated with inferior clinical outcomes in patients with large B-cell lymphoma receiving anti-CD19 CAR T-cell therapy
    Meeting Abstract

    Nath, K.; Alarcon Tomas, A.; Flynn, J.; Fein, J. A.; Alperovich, A.; Anagnostou, T.; Batlevi, C. W.; Dahi, P. B.; Fingrut, W.; Giralt, S. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • IL-22 treatment overcomes corticosteroid-mediated suppression of epithelial regeneration and exacerbation of gvhd-associated GI damage
    Meeting Abstract

    Arnhold, V.; Jansen, S. A.; Chang, W.; Thangavelu, G.; Vinci, P.; Takashima, S.; Egorova, A.; Kuttiyara, J.; Liu, C.; Calafiore, M.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • The amphiregulin/EGFR axis regulates donor T cell expansion and contributes to intestinal GVHD pathology after allogeneic bone marrow transplantation
    Meeting Abstract

    Ito. T.; Takashima, S.; Calafiore, M.; Fu, Y. Y.; Egorova, A.; Kuttiyara, J.; Chang, W.; Vinci, P.; Arnhold, V.; Zaiss, D.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Interim analysis of the 2nd chance protocol: A multicenter trial of daratumumab, carfilzomib, lenalidomide, & dexamethasone for relapsed/refractory myeloma with salvage autologous hematopoietic cell transplantation
    Meeting Abstract

    Shah, G. L.; Bal, S.; Rodriguez, C.; Chhabra, S.; Bayer, R. L.; Costa, L. J.; Lambird, J.; Ferrer, C.; Parascondola, A.; Marcello, L.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save

    • Transplantation and Cellular Therapy – authorized name for:

    Name ISSN / ISBN Publisher
    Transplantation and Cellular Therapy 26666367 Elsevier Inc.
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 26666367 Unknown
    Transplantation and Cellular Therapy 26666375 Unknown
    Transplantation and Cellular Therapy 2666-6375 Elsevier Inc.
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 26666367 American Society for Transplantation and Cellular Therapy
    Transplantation and Cellular Therapy 26666367 2020
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 26666375 The American Society for Transplantation and Cellular Therapy
    Transplantation and Cellular Therapy 26666367 2021
    Transplantation and Cellular Therapy 26666375 2024
    Transplantation and Cellular Therapy 26666375 Elsevier B.V.
    Transplantation and Cellular Therapy 2666-6375 Elsevier Science, Inc.
    Transplantation and Cellular Therapy 2666-6375 Elsevier Science, Inc.
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 26666367 2023
    Transplantation and Cellular Therapy 26666375 The Authors
    Transplantation and Cellular Therapy 26666367 2022
    Transplantation and Cellular Therapy 26666367 The American Society for Transplantation and Cellular Therapy
    Transplantation and Cellular Therapy 26666367 Elsevier Inc.
    Transplantation and Cellular Therapy 26666367 2024
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Unknown (26666375) 26666375 Elsevier B.V.